160 related articles for article (PubMed ID: 37749528)
1. Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes.
Montazeri Z; Hashemi-Madani N; Iraji H; Sohrabi M; Alaei-Shahmiri F; Emami Z; Babaei MR; Malek M; Khamseh ME
BMC Endocr Disord; 2023 Sep; 23(1):202. PubMed ID: 37749528
[TBL] [Abstract][Full Text] [Related]
2. Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors.
Pastori D; Loffredo L; Perri L; Baratta F; Scardella L; Polimeni L; Pani A; Brancorsini M; Albanese F; Catasca E; Del Ben M; Violi F; Angelico F
Am J Cardiol; 2015 May; 115(10):1402-6. PubMed ID: 25776455
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
[TBL] [Abstract][Full Text] [Related]
5. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
[TBL] [Abstract][Full Text] [Related]
7. Prevalences of Hypertension, Type 2 Diabetes Mellitus, and Cardiovascular Disease in a Cohort of Puerto Ricans with Non-alcoholic Fatty Liver Disease.
González-Rivera A; Vargas-Figueroa VM; Candal-Rivera E; Torres EA
P R Health Sci J; 2024 Mar; 43(1):18-24. PubMed ID: 38512757
[TBL] [Abstract][Full Text] [Related]
8. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
Ampuero J; Aller R; Gallego-Durán R; Crespo J; Calleja JL; García-Monzón C; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Albillos A; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Guerra MH; Augustín S; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero Gómez M;
J Hepatol; 2020 Jul; 73(1):17-25. PubMed ID: 32147361
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure.
Misan IA; Arisheva OS; Garmash IV; Cabello FR; Kobalava ZD
Kardiologiia; 2023 Dec; 63(12):72-76. PubMed ID: 38156493
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.
Sun Y; Hong L; Huang Z; Wang L; Xiong Y; Zong S; Zhang R; Liu J; Zang S
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3661-e3669. PubMed ID: 35766414
[TBL] [Abstract][Full Text] [Related]
13. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
[TBL] [Abstract][Full Text] [Related]
14. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
[TBL] [Abstract][Full Text] [Related]
15. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
Kim KS; Hong S; Han K; Park CY
BMJ; 2024 Feb; 384():e076388. PubMed ID: 38350680
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease is associated with an increased risk of type 2 diabetes.
Loosen SH; Krieg S; Krieg A; Qvartskhava N; Luedde T; Kostev K; Roderburg C
Eur J Gastroenterol Hepatol; 2023 Jun; 35(6):662-667. PubMed ID: 37115964
[TBL] [Abstract][Full Text] [Related]
17. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo A; Nascimbeni F; Mantovani A; Targher G
J Hepatol; 2018 Feb; 68(2):335-352. PubMed ID: 29122390
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Theofilis P; Vordoni A; Nakas N; Kalaitzidis RG
Life (Basel); 2022 May; 12(5):. PubMed ID: 35629385
[TBL] [Abstract][Full Text] [Related]
19. Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial.
Attaran F; Emami S; Sohrabi M; Malek M; Ajdarkosh H; Khoonsari M; Ismail-Beigi F; Khamseh ME
BMC Gastroenterol; 2023 Sep; 23(1):327. PubMed ID: 37742004
[TBL] [Abstract][Full Text] [Related]
20. Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study.
Mikolasevic I; Domislovic V; Turk Wensveen T; Delija B; Klapan M; Juric T; Lukic A; Mijic A; Skenderevic N; Puz P; Ostojic A; Krznaric Z; Radic-Kristo D; Filipec Kanizaj T; Stimac D
Eur J Intern Med; 2020 Dec; 82():68-75. PubMed ID: 32839076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
